SIG-Cardiac presents "Artificial Intelligence in Diagnosis and Treatment of Cardiovascular Diseases"

Tuesday 12th August 2025

We are thrilled to invite you to the MICCAI SIG-Cardiac August webinar:

Artificial Intelligence in Diagnosis and Treatment of Cardiovascular Diseases.

Date: August 24, 2025
Time: 10:00 GMT (Check your local time: 6:00 New York | 11:00 London | 18:00 Beijing | 20:00 Sydney | 12:00 Germany)
Platform: Zoom (Meeting ID: 262 909 6153 | Password: 863757) "

Featured Speaker: Xiaowei Xu
-  Associate Professor and Director of the Laboratory of Cardiovascular Artificial Intelligence and 3D Technology at Guangdong Provincial People’s Hospital.

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, underscoring the urgent need for accurate diagnosis, personalized treatment strategies, and efficient clinical decision-making. In recent years, artificial intelligence (AI) has emerged as a powerful enabler in cardiovascular medicine, offering advancements in image-based analysis, predictive modeling, and therapeutic planning. In this talk, we present our recent research efforts in AI-driven segmentation, disease diagnosis, prognosis prediction, and surgical planning. Through a series of clinical case studies and methodological innovations, we demonstrate how AI can enhance the precision and efficiency of cardiovascular care. We also discuss key challenges in model deployment, including data quality, interpretability, and integration into clinical workflows. This presentation aims to highlight the transformative potential of AI in improving outcomes for patients with cardiovascular diseases.

Biography:

Dr. Xiaowei Xu is an Associate Professor and Director of the Laboratory of Cardiovascular Artificial Intelligence and 3D Technology at Guangdong Provincial People’s Hospital. He is a recipient of the Guangdong Special Support Program for High-level Young Talents and a Humboldt Research Fellow in Germany. His research focuses on the development and application of artificial intelligence in cardiovascular medicine. Dr. Xu has conducted extensive work in the field of medical AI, with over 100 peer-reviewed publications. He serves as an Associate Editor for Pattern Recognition. He is the principal investigator of multiple research projects, including those funded by the National Natural Science Foundation of China (NSFC) and the Guangdong Special Support Program. Dr. Xu received both his BASc and PhD degrees from Huazhong University of Science and Technology in 2011 and 2016, respectively.